Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-10-038802
Filing Date
2010-09-28
Accepted
2010-09-28 16:31:24
Documents
1
Period of Report
2010-09-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3992
  Complete submission text file 0001140361-10-038802.txt   5754
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 88 SIDNEY ST CAMBRIDGE MA 02139
Business Address
RICH ALEXANDER (Reporting) CIK: 0001236445 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14656 | Film No.: 101094099